“High-Cost Drugs”

78 result(s)
Drug Pipeline
Getting personal with mRNA cancer vaccines
Getting personal with mRNA vaccines for cancer More
Briefing
Cost Management
Considering the complexities and cost of radiation oncology
Strategies for delivering more efficient and effective care that costs less More
Briefing
Care Management
Improve GLP-1 effectiveness for weight loss with condition management
Drive sustainable member behavior change for better health outcomes and cost savings More
Briefing
Cost Management
Keeping Medications Affordable for Members
Keeping medications affordable for members More
Briefing
Drug Pipeline
Managing New Drug Options for Obesity
... More
Briefing
Drug Pipeline
Advances in Delivering Gene Therapies
The different types of gene therapy and how they work More
Briefing
Female caregiver and elderly patient discussing medical information on a couch
Specialty
Safer Options for Infusion Treatments
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Icon of an infusion bag, overlaying a rising line graph
Specialty
Managing the MS Cost Challenge
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment... More
Briefing
Drug Pipeline
What's Next for Hemophilia Treatments?
What's Next for Hemophilia Therapy and New Treatment Options? More
Briefing
Specialty
High-Touch, Whole Patient Care for PAH
PAH is a rare, life-threatening disease, which is incurable. It is difficult to manage and to help ensure the longest survival and best possible quality of life, members need... More
Briefing